Apellis Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.

About APLS

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE.

CEO

Cedric Francois

CEOCedric Francois

Employees

706

Employees706

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2009

Founded2009

Employees

706

Employees706

APLS Key Statistics

Market cap

5.89B

Market cap5.89B

Price-Earnings ratio

-10.89

Price-Earnings ratio-10.89

Dividend yield

—

Dividend yield—

Average volume

1.91M

Average volume1.91M

High today

$49.45

High today$49.45

Low today

$49.00

Low today$49.00

Open price

$47.32

Open price$47.32

Volume

4.41K

Volume4.41K

52 Week high

$94.75

52 Week high$94.75

52 Week low

$19.83

52 Week low$19.83

APLS News

Benzinga 7d

A Closer Look at Apellis Pharmaceuticals's Options Market Dynamics - Apellis Pharmaceuticals (NASDAQ:APLS - Benzinga

Loading... Loading... Financial giants have made a conspicuous bearish move on Apellis Pharmaceuticals. Our analysis of options history for Apellis Pharmaceuti...

Yahoo Finance 7d

Will Apellis Pharmaceuticals, Inc. Report Negative Earnings Next Week? What You Should Know - Yahoo Finance

Apellis Pharmaceuticals, Inc. (APLS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter end...

Analyst ratings

82%

of 17 ratings

Buy

82.4%

Hold

17.6%

Sell